- Circle shares fall despite earnings beat as revenue misses
- ConocoPhillips (COP.US): Forecasts third-quarter daily production at 2.29 million to 2.32 million barrels of oil equivalent (market estimate: 2.32 million barrels).
- Market news: The UK's Competition and Markets Authority (CMA) will not refer the Paramount and Warner Bros. Discovery (WBD.US) deal for an in-depth investigation.
- Rogers Sugar expects steady fiscal 2026 results despite evolving market conditions
- Tarsus to buy Alkeus in deal worth about $450 million upfront
- Scholar Rock Q2 FY26 net loss narrows to $109.9 million; revenue remains no revenue
- Xeris Q2 FY26 net loss widens to $31.1 million; revenue rises 29% to $92.1 million
- Monte Rosa Q2 FY26 net loss widens to $43.4 million; revenue falls 61.3% to $9 million
- Tarsus prices USD 125 million PIPE at USD 56 per share
- ICG says private company EBITDA growth holds up despite geopolitical shocks
- Bausch + Lomb adds Bausch Health CEO Thomas Appio to board
- Bluelinea liquidity contract holds 55,558 shares, EUR 9,603.39 at June 30
- OpenText Q4 FY26 GAAP EPS more than doubles to US$ 0.64; revenue rises 2.9% to US$ 1.35 billion
- INSULET CORPORATION : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $145 FROM $247
- CareCloud Backs 2026 Rev $128M-$132M >CCLD
- Versant Media Group Raises FY26 View To Rev $6.2B-$6.45B >VSNT
- Bluelinea says APICIL raises stake to 85.14% of shares, 85.53% of voting rights
- Real Brokerage Q2 FY26 net loss turns to USD 8 million; revenue rises 30% to USD 700.6 million
- Luca Mining intersects 184 m of gold-silver mineralization at Campo Morado’s Largo Norte zone
- CareCloud 2Q Adjusted EBITDA $5.9M >CCLD
- Fresenius shifts share bylaws to registered stock structure, sets Aug. 13 trading switch
- Medtronic wins FDA breakthrough device tag for Sphere-9 ventricular arrhythmia catheter
- Aeva management participates in Canaccord Genuity Annual Growth Conference
- Korro Bio Q2 FY26 net loss narrows to USD 18.92 million; revenue posts no collaboration revenue
- Immunocore Q2 FY26 net loss narrows to $0.8 million; revenue rises 18% to $115.9 million
- BKV Q2 FY26 net income falls 29.68% to $75.8 million; adjusted EBITDAX climbs 47.15% to $142 million
- Tarsus Q2 FY26 net loss narrows 8.77% to $18.55 million; net product sales rise more than 69% to $173.91 million
- Viridian net loss widens to $127.12 million in Q2 FY26; SG&A expenses climb to $54.98 million
- Paramount Resources Q2 FY26 net income rises 1,526% to $68.3 million
- Monte Rosa Therapeutics 2Q Research and Development $48.0M >GLUE
- ConocoPhillips: Andy O'Brien Named Pres and CEO
- Climb Bio Q2 FY26 net loss widens 55.73% to $13.5 million
- Cullinan Q2 FY26 net loss narrows 23.36% to $53.7 million
- Rogers Sugar FY26 Q3 net income drops 16.42% to $12.06 million; revenue falls 8.35% to $293.7 million
- Versant net income drops 30.1% to $211 million in FY26 Q2; revenue falls 3.8% to $1.64 billion
- Zoetis names Jay Saccaro CFO, COO effective Aug. 17, 2026
- Opus Genetics Q2 FY26 net loss widens to $8.1 million; revenue drops to $755,000
- Amylyx Q2 FY26 net loss widens to $43.4 million; SG&A expenses climb to $21.9 million
- Versant Media Group 2Q EPS $1.49 >VSNT
- Ligand Pharmaceuticals Adjusts FY View To Adj EPS $9.00-Adj EPS $9.50 >LGND
- Vistance Networks 2Q Sales $319.6M >VISN
- Monte Rosa Therapeutics 2Q Rev $8.97M >GLUE
- Mastech Digital Q2 FY26 GAAP net income turns to loss of $100,000; revenue drops 15.6% to $41.45 million year over year
- Iovance Q2 operating loss narrows to $51.91 million; revenue rises 66% year over year to $99.31 million
- CPI Card Group Q2 FY26 net income swings to profit of $2 million; revenue rises 15% to $149 million
- Evergy Q2 FY26 GAAP EPS rises to $0.91; adjusted EPS climbs to $0.88
- Aclaris Q2 FY26 net loss widens to $21.5 million; revenue slips to $1.6 million
- Roivant Sciences 1Q Rev $1.44M >ROIV
- Roivant Sciences 1Q Loss/Shr 26c >ROIV
- Ligand Q2 FY26 adjusted EPS climbs 48% to $2.37; revenue rises 34% to $63.7 million
- Intellia Q2 FY26 net loss widens to $106.63 million; revenue falls to $7.66 million
- Fresenius shifts to registered shares, starts trading under new ISIN on Aug. 13, 2026
- Federal Realty launches private placement of $400 million exchangeable senior notes due 2031
- ConocoPhillips 2Q26 EPS more than doubles to $3.23 year over year
- Resolute Holdings Mgmt 2Q Sales $473.2M >RHLD
- Xeris Biopharma Narrows FY View To Rev $385M-$390M >XERS
- Resolute Holdings Mgmt 2Q Loss/Shr $1.53 >RHLD
- KLAVIYO, INC. <KVYO.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $30 FROM $35
- FLUTTER ENTERTAINMENT PLC <FLUT.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $120 FROM $130
- Macerich plans USD 600 million exchangeable senior notes offering due 2031
- Fiserv Q2 FY26 GAAP EPS drops 37% to $1.17; revenue falls 4% to $5.29 billion
- LENNAR CORP <LEN.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $80 FROM $90
- Commerce Q2 FY26 swings to GAAP net income of $1.1 million; revenue rises 0.1% to $84.5 million vs year-ago quarter
- USA Rare Earth updates financial calendar ahead of quarterly results release and investor call
- Sotera Health Q2 net income rises to $54 million; net revenues increase 9.2% to $321.38 million vs Q2 2025
- ENCORE CAPITAL GROUP, INC. <ECPG.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $112 FROM $105
- Bentley Systems Q2 FY26 net income per diluted share rises 13.64% to $0.25; revenue climbs 12.8% to $410.7 million
- MEDLINE INC. <MDLN.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $47 FROM $56
- Bentley Systems 2Q Adj EPS 35c >BSY
- TIC Solutions 2Q Loss $13.3M >TIC
- TIC Solutions 2Q Loss/Shr 6c >TIC
- Rogers Sugar: For FY26, in Maple, Co Expects Lower Contribution as Current Global Demand Has Decreased in Recent Mos, Reflecting Impact of Food Inflation >RSI.T
- EOG RESOURCES, INC. <EOG.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $153 FROM $134
- Evolent Q2 FY26 net loss narrows to $28.36 million; revenue rises 46.84% to $652.52 million
- INSULET CORPORATION : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $145 FROM $247
- PACS GROUP, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $62 FROM $52
- Vistance Networks declares USD 5 special cash distribution per share
- Arbe Robotics Q2 FY26 net loss widens to $10.2 million; revenue rises to $0.7 million
- Unity Q2 FY26 GAAP net loss narrows to $23 million; revenue rises 24% to $546 million
- Viatris Q2 FY26 net loss widens to $119 million; revenue rises 5% to $3.8 billion
- MSC Income Fund declares Q4 regular monthly dividend of $0.11 per share for October-December 2026
- DUOLINGO, INC. <DUOL.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $120 FROM $100
- SHOPIFY INC. <SHOP.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $180 FROM $150
- GPGI swings to GAAP profit in Q2 FY26; pro forma adjusted net sales fall 4% to USD 473.2 million
- Roivant unit Priovant begins Phase 3 BEACON+ trial of brepocitinib in cutaneous sarcoidosis
- Roivant Q1 FY27 net loss widens to $290.61 million; revenue slips to $1.44 million
- DOORDASH <DASH.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $336 FROM $330
- SKYWARD SPECIALTY INSURANCE GROUP INC <SKWD.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $75 FROM $70
- Starwood Property Trust 2Q EPS 1c >STWD
- Axia Energia sets redemption of class C preferred shares at BRL 53.71 each
- AGILON HEALTH, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $114 FROM $92
- DIODES INCORPORATED <DIOD.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $133 FROM $139
- TTM TECHNOLOGIES INC <TTMI.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $224 FROM $215
- Reka Industrial corrects near-term outlook wording in H1 report
- DIANTHUS THERAPEUTICS INC <DNTH.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $128 FROM $110
- Vital Farms Q2 FY26 net loss widens to $31.07 million; revenue falls 10.1% to $166.03 million
- Frontdoor Q2 net income rises 13% to $125 million; revenue increases 5% to $645 million
- PENN Entertainment 2Q Rev $1.86B >PENN
- Bentley Systems 2Q Net $78.6M >BSY
- PENN Entertainment 2Q EPS 24c >PENN
